Health Care Cost in Patients Undergoing Electrical Cardioversion: An Analysis From the Edoxaban Versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Study
Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.1190
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2017
Authors
Publisher
Elsevier BV